@article{article, title = {{Tralokinumab for moderate鈥恡o鈥恠evere atopic dermatitis: results from two聽52鈥恮eek, randomized, double鈥恇lind, multicentre, placebo鈥恈ontrolled phase III trials (ECZTRA 1 and ECZTRA 2)}}, publisher = {{Wiley}}, url = {{}}, year = {{2020}}, month = {{9}}, author = {{Wollenberg A and Blauvelt A and Guttman鈥怸assky E and Worm M and Lynde C and Lacour J and Spelman L and Katoh N and Saeki H and Poulin Y and Lesiak A et al}}, doi = {{10.1111/bjd.19574}}, journal = {{British Journal of Dermatology}}, note = {{Accessed on 2025/05/17}}}